DK1501505T3 - Anvendelse af (3-(2-ethylphenyl)-5-methoxyphenyl)-1H-1,2,4 -triazol til behandling af autoimmune sygdomme - Google Patents

Anvendelse af (3-(2-ethylphenyl)-5-methoxyphenyl)-1H-1,2,4 -triazol til behandling af autoimmune sygdomme

Info

Publication number
DK1501505T3
DK1501505T3 DK03720879T DK03720879T DK1501505T3 DK 1501505 T3 DK1501505 T3 DK 1501505T3 DK 03720879 T DK03720879 T DK 03720879T DK 03720879 T DK03720879 T DK 03720879T DK 1501505 T3 DK1501505 T3 DK 1501505T3
Authority
DK
Denmark
Prior art keywords
ethylphenyl
subject
triazole
methoxyphenyl
treatment
Prior art date
Application number
DK03720879T
Other languages
English (en)
Inventor
L Battistini
G Borsellino
Santis R De
P Carminati
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of DK1501505T3 publication Critical patent/DK1501505T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK03720879T 2002-05-03 2003-04-15 Anvendelse af (3-(2-ethylphenyl)-5-methoxyphenyl)-1H-1,2,4 -triazol til behandling af autoimmune sygdomme DK1501505T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/137,699 US6797722B2 (en) 2002-05-03 2002-05-03 Use of 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole for the treatment of autoimmune diseases

Publications (1)

Publication Number Publication Date
DK1501505T3 true DK1501505T3 (da) 2006-05-22

Family

ID=29269138

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03720879T DK1501505T3 (da) 2002-05-03 2003-04-15 Anvendelse af (3-(2-ethylphenyl)-5-methoxyphenyl)-1H-1,2,4 -triazol til behandling af autoimmune sygdomme

Country Status (15)

Country Link
US (2) US6797722B2 (da)
EP (1) EP1501505B1 (da)
JP (1) JP2005529904A (da)
KR (1) KR20040111491A (da)
AT (1) ATE315935T1 (da)
AU (1) AU2003224453A1 (da)
CA (1) CA2483904A1 (da)
DE (1) DE60303296T2 (da)
DK (1) DK1501505T3 (da)
ES (1) ES2257666T3 (da)
MX (1) MXPA04010785A (da)
PL (1) PL374252A1 (da)
PT (1) PT1501505E (da)
TW (1) TWI284532B (da)
WO (1) WO2003092681A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY142651A (en) * 2003-03-18 2010-12-15 Merck Sharp & Dohme Biaryl substituted triazoles as sodium channel blockers
WO2005077411A2 (en) * 2004-02-10 2005-08-25 Innate Pharma Composition and method for the treatment of carcinoma
EP1921073A1 (en) 2006-11-10 2008-05-14 Laboratorios del Dr. Esteve S.A. 1,2,4-Triazole derivatives as sigma receptor inhibitors

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4379155A (en) * 1979-06-11 1983-04-05 Gruppo Lepetit S.P.A. 3,5-Disubstituted-1H-1,2,4-triazole derivatives
JPS58126810A (ja) * 1981-12-24 1983-07-28 Kaken Pharmaceut Co Ltd 抗炎症眼科用液剤およびその製法
DE3808283A1 (de) * 1988-03-12 1989-09-21 Boehringer Ingelheim Kg Neue 3,4,5-substituierte 4h-1,2,4-triazole, ihre herstellung und verwendung
US4895872A (en) * 1989-03-15 1990-01-23 Cetus Corporation Immunosupressive analogues and derivatives of succinylacetone
US5273979A (en) * 1991-08-01 1993-12-28 Merck & Co., Inc. C-31 desmethyl FR-900520 cyclic hemiketal immunosuppressant agent
US5189042A (en) * 1991-08-22 1993-02-23 Merck & Co. Inc. Fluoromacrolides having immunosuppressive activity
US5484788A (en) * 1993-03-26 1996-01-16 Beth Israel Hospital Association Buspirone as a systemic immunosuppressant
DE4320801A1 (de) * 1993-06-23 1995-01-05 Fahlberg List Pharma Gmbh 2-Hydroxyphenylsubstituierte 1,2,4-Triazole und 1,2,4-Oxadiazole, ihre Verwendung als pharmazeutische Wirkstoffe und sie enthaltende Arzneimittel
WO1997026278A1 (en) * 1996-01-18 1997-07-24 Steeno Research Group A/S Synthetic il-10 analogues
ATE298740T1 (de) * 1997-04-04 2005-07-15 Mitsubishi Pharma Corp 2-aminopropan-1,3-diol-verbindungen, ihre medizinische anwendung und zwischenprodukte zu ihrer synthese
IT1292092B1 (it) * 1997-06-05 1999-01-25 Geange Ltd Impiego di derivati eterociclici aromatici azotati nel trattamento topico di affezioni di tessuti epiteliali
EP1099695A1 (en) * 1999-11-09 2001-05-16 Laboratoire Theramex S.A. 5-aryl-1H-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
KR20040111491A (ko) 2004-12-31
EP1501505B1 (en) 2006-01-18
ATE315935T1 (de) 2006-02-15
DE60303296D1 (de) 2006-04-06
CA2483904A1 (en) 2003-11-13
EP1501505A1 (en) 2005-02-02
US20050026980A1 (en) 2005-02-03
TWI284532B (en) 2007-08-01
WO2003092681A1 (en) 2003-11-13
MXPA04010785A (es) 2005-03-07
US20030207931A1 (en) 2003-11-06
AU2003224453A1 (en) 2003-11-17
PT1501505E (pt) 2006-05-31
DE60303296T2 (de) 2006-08-17
TW200418464A (en) 2004-10-01
PL374252A1 (en) 2005-10-03
ES2257666T3 (es) 2006-08-01
JP2005529904A (ja) 2005-10-06
US6797722B2 (en) 2004-09-28

Similar Documents

Publication Publication Date Title
DE60224879D1 (de) Verwendung von dpiv-inhibitoren als therapeutika für krankhafte neurologische zustände
EA199800119A1 (ru) Ингибиторы адгезии клеток
NO995544L (no) Forbindelser og metoder for inhibering av ekspresjonen av VCAM-1
WO2003009773A8 (en) Removable stent and method of using the same
MX9606546A (es) Compuestos inhibidores de la enzima conversiva de interleukina-1 beta.
HK1067120A1 (en) Glutaminyl based dpiv inhibitors
DE69939165D1 (de) N,n-disubstituierte amide welche die bindung von integrinen an ihre rezeptoren hemmen
EA200500856A1 (ru) Новые химические соединения
ATE244234T1 (de) Substituierte imidazole zur behandlung von entzündlichen krankheiten
EA199700135A1 (ru) Ингибиторы клеточной адгезии
ATE553128T1 (de) Anti-ngf-antikörper und verfahren zu ihrer verwendung
ATE113793T1 (de) Verfahren zur fungiziden blattbehandlung mit einem triazol und fungizide zusammensetzung zur durchführung dieses verfahrens.
ATE171212T1 (de) Corticotropin freisetzende rezeptoren des faktor 2
ES2160593T3 (es) Desosamino-derivados de microlidos como inmunosupresores y agentes antifungicos.
DK1501505T3 (da) Anvendelse af (3-(2-ethylphenyl)-5-methoxyphenyl)-1H-1,2,4 -triazol til behandling af autoimmune sygdomme
AP2000001992A0 (en) Succinamide inhibitors of inteleukin-1B converting enzyme.
DK0804465T3 (da) Nye elastaseinhibitorer
ATE445235T1 (de) Verfahren zur herstellung von zinkpulver- agglomeraten und diese enthaltenden artikel
ATE367728T1 (de) Verfahren zur pufferverwaltung
WO2005089736A3 (en) Methods for treating inflammatory and autoimmune diseases
DE60233555D1 (de) Die nukleotidsequenz ann bindende zink-finger domänen
FI853948A0 (fi) Foerbaettrad komposition av antiinflammatoriska droger.
DE60320848D1 (de) Verwendung von cc-chemokine ccl5/rantes mutanten zur behandlung von lebererkrankungen
DE50003587D1 (de) Verbundelemente
WO2004099251A3 (en) Compositions and methods for treatment of cryptococcosis